http://investor.sangamo.com/releases.cfm?sh_auth=0.0.0.ad1dcb691ef81696c0c02ea27e385165Sangamo BioSciences, Inc. - General Releasesen-usShareholder.com RSS Feedhttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=765879Mon, 20 May 2013 11:00:00 GMThttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=765879Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseaseshttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=764989Wed, 15 May 2013 14:00:00 GMThttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=764989Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic®, SB-728-Thttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=763662Thu, 09 May 2013 20:05:00 GMThttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=763662Sangamo BioSciences Announces Presentation at the Bank of America Merrill Lynch 2013 Health Care Conferencehttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=763207Wed, 08 May 2013 20:02:00 GMThttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=763207Sangamo BioSciences Reports First Quarter 2013 Financial Resultshttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=761089Wed, 01 May 2013 20:05:00 GMThttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=761089Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcasthttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=759085Wed, 24 Apr 2013 20:05:00 GMThttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=759085Sangamo BioSciences Announces Presentation At The Needham Healthcare Conferencehttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=755692Wed, 10 Apr 2013 20:05:00 GMThttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=755692Sangamo BioSciences Announces Presentation At Regen Med Investor Dayhttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=745967Wed, 06 Mar 2013 16:46:00 GMThttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=745967Sangamo Presents New Clinical Data at CROI 2013 Demonstrating Persistent Immune System Improvements After Treatment With ZFN Therapeutic® SB-728-Thttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=745434Tue, 05 Mar 2013 21:05:00 GMThttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=745434Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conferencehttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=743815Wed, 27 Feb 2013 21:02:00 GMThttp://investor.sangamo.com/releasedetail.cfm?ReleaseID=743815Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference